CSF IgG levels in MS patients were significantly higher compared to IgA (fold change = 2.65, p < 0.001; Figure 1A) and IgM (fold change = 2.15, p < 0.001; Figure 1A). This evidence concerns the gene CD79A and myeloid sarcoma.